JOHANNE BLOUNT: Open Payments
NPI 1295346542 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,967 in 65 payments from 24 companies in 2025. Trend: 2023 $448 · 2024 $2,263 · 2025 $1,967
Food & beverage: $1,967
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $194 |
| GlaxoSmithKline, LLC. | 7 | $175 |
| ABBVIE INC. | 1 | $149 |
| Eisai Inc. | 6 | $145 |
| PUMA BIOTECHNOLOGY, INC. | 6 | $139 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Lilly USA, LLC | 5 | $116 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $114 |
| GENZYME CORPORATION | 1 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
Products named: Lenvima, NERLYNX, OPDIVO, VERZENIO, DUPIXENT, OJJAARA, TECVAYLI, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
